Clinical Trial: Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Regulatory B Cells in Inflammatory Rheumatisms, Systemic Auto-immune Diseases in Adults and Biomarkers of Response to Biologic Treatments

Brief Summary: B cells are known to play an important role in auto-immune diseases by activating T cells, secreting inflammatory cytokines and autoreactive antibodies. However, a sub-type of B cells named regulatory B cells or Bregs has recently shown capacities to prevent or cure arthritis in mouse models. Bregs have also been identified in humans.